Orforglipron, aleniglipron, and AZD5004 are oral GLP-1s chasing injectable-like results
Best fit: Women dealing with metabolic conditions where general weight-loss telehealth misses important context
If ongoing randomized trials confirm current findings, these medications could shift addiction treatment away from a substance-specific model toward a circuit-based model of reward regulation
Some frameworks suggest that the interaction of these peptides could influence intracellular mediators relevant to receptor activation and downstream transcriptional regulators
Pharmacol Biochem Behav 163:5765 Tomaz V, Chaves Filho A, Cordeiro R, Juc P, Soares M, Barroso P, Cristino L, Jiang W, Teixeira A, de Lucena D, Macedo D (2020) Antidepressants of different classes cause distinct behavioral and brain pro- and anti-inflammatory changes in mice submitted to an inflammatory model of depression